Chapter 4 of 26 · Corporate Restructuring, Valuation and Insolvency

Process of M&A Transactions

26 questionsasked in 12 of 15 attemptsOrder: by topic, latest first

Chapter weightageCh. 3Ch. 5
Questions per attemptTap a bar to filter
J22D22J23
June 2026Q. 1(a)5 marksSyllabus 2022
Show the facts common to all parts of Q. 1

The Indian healthcare sector is undergoing rapid consolidation. ‘‘Aarogya Healthcare,’’ a large, publicly listed hospital chain with a strong presence in South India, is looking to expand its reach and service offerings. They have identified ‘‘Swasth Jeevan Clinics,’’ a smaller but well -regarded chain of clinics specializing in primary care and diagnostics, as an attractive acquisition target. Swasth Jeevan Clinics has a strong brand reputation in Western India and a loyal patient base.

Aarogya Healthcare believes that acquiring Swasth Jeevan Clinics will:

•Expand its geographic footprint into Western India.

•Diversify its service offerings into primary care and diagnostics.

•Gain access to Swasth Jeevan Clinics’ established patient base a nd brand.

•Achieve synergies through economies of scale and shared resources.

The proposed transaction is structured as an amalgamation, where Swasth Jeevan Clinics will merge into Aarogya Healthcare.

Key Individuals:

•Dr. Lakshmi Reddy : CEO of Aarogya Healthcare

•Mr. Sanjay Desai : CFO of Aarogya Healthcare

•Dr. Priya Sharma : CEO of Swasth Jeevan Clinics

•Mr. Rohan Verma : Lead Partner at ‘‘Verma and Associates,’’ the investment bank advising Aarogya Healthcare.

(a)Mr. Rohan Verma from Verma & Associates is preparing a presentation for Dr. Lakshmi Reddy and Mr. Sanjay Desai on the strategic rationale for the acquisition and the key areas of due diligence.

•Explain three potential synergies that Aarogya Healthcare could achieve through the acquisition of Swasth Jeevan Clinics. Provide examples that are specific and relevant to the healthcare sector only.

•Identify two key areas of due diligence that Aarogya Healthcare should conduct on Swasth Jeevan Clinics beyond the standard financial due diligence. Explain why each area is important in this specific acquisition scenario.

June 2026Q. 2(c)5 marksSyllabus 2022

(c)Due Diligence is an investigation or audit of a potential investment. It seeks to confirm all material facts in regard to a sale. It is a way of preventing unnecessary harm/ hassles to either party involved in a transaction. Briefly explain different types of due diligence that are typically conducted during a Mergers & Acquisitions (M & A) transaction.

June 2026Q. 2A(iii)5 marksSyllabus 2022

(iii)StellarTech, a privately held company specializing in innovative battery technology for electric vehicles, has experienced rapid growth in recent years. Founded by Ava Sharma and Ben Carter, StellarTech has developed a ground-breaking battery with significantly improved energy density and charging speed. However, to scale up production and meet growing demand, StellarTech requires substantial capital investment.

NovaCorp, a publicly listed company in the renewable energy sector, has struggled to maintain profitability and relevance in the face of increasing competition. Catherine Dubois, NovaCorp’s CEO, recognizes the need for a strategic shift and is actively seeking opportunities to revitalize the company.

StellarTech and NovaCorp have identified a potential reverse acquistion as a mutally beneficial solution. StellarTech would gain access to the public markets and NovaCorp’s listing, while NovaCorp would acquire a promising technology and a new growth engine. The proposed deal would result in StellarTech’s sharehol ders owning 70% of the combined entity, with Ava Sharma becoming the CEO of the newly formed company, ‘‘StellarNova Technologies’’

From StellarTech’s perspective, what are the primary reasons for considering a reverse acquisition with NovaCorp instead of pursuing a traditional Initial Public Offering (IPO)? Identify and analyse the key risks associated with this reverse acquisition for both StellarTech and NovaCorp.

December 2025Q. 1(c)5 marksSyllabus 2022
Show the facts common to all parts of Q. 1

Alkasa Lifesciences Limited (ALF Ltd.), a public limited company, is a healthcare conglomerate, with its operations in four major verticals–Pharmaceutical Manufacturing, Medical Equipment, Wellness and Nutrition Products and Diagnostics. ALF Ltd.’s, 75-year-old traditional Pharma business, is the backbone of the company. However, over the past few years, the company has expanded its operations through the Wellness and Nutrition division which has experienced rapid growth, driven by rising demand for preventive health products. Evercare Path Labs, a wholly owned subsidiary, is yet another diversification venture of ALF Ltd. which though is a high-growth unit but lacks synergy with the other pharma activities.

The stakeholders have raised concerns that the company’s diversified structure might dilute the overall performance and valuation of the company. Investing too much in expansion without a clear strategy can make the business vulnerable to market changes or operational failures, increasing the risk of substantial financial losses. Hence, they suggest to shed off the non-core units to focus on core areas. But the management feels a strong sense of ownership and pride over the units they have personally developed and nurtured, making it difficult to let them go. Hence the suggestion of divestiture is completely unacceptable to them.

In response to this deadlock, the Board of Directors have hired Mr. Agrim Basu as their Strategic advisor for exploring strategic options to unlock the value of the high-growth divisions and improving focus on its core pharmaceutical operations. Mr. Basu has suggested a scheme explaining that the company may opt for a divestiture, capital restructuring, buyback and acquisitions/mergers as part of a strategic initiative to enhance shareholder value and optimize operational focus. Together, these steps will reflect proactive financial management and strategic clarity, positioning the company for sustainable long-term growth while maintaining investor trust and market competitiveness.

Convinced with the suggestions of Mr. Basu, the following scheme is formulated :

•Divest Evercare Path Labs or Separate Evercare Path Labs for value unlocking (via carveout) as diagnostics business no longer aligns with ALF Ltd.’s long-term strategic direction.

•Use proceeds from above step to repay high-interest debt of ₹ 500 crore to improve debtequity ratio and further support financial stability.

•Further, a buyback of shares under Section 68 of the Companies Act, 2013, utilizing ₹ 800 crores of the proceeds. Improved EPS from buyback may help in market perception during future takeover bids, potentially reducing acquisition cost.

•With remaining proceeds and a stronger financial position post-buyback, ALF Ltd. will be all set for mergers/acquisition.

The process of merging with another company or acquiring a company is complex. In addition to the legal ramifications, companies must be aware of the potential tax implications as well as ensuring that the terms of the deal benefit both parties.

ALF Ltd. has created a team of strategic advisors, lawyers and professionals to negotiate on their behalf in order to obtain the best possible deal within the framework of the applicable laws.

After rounds of deliberations and due diligence of various options proposed by the special team, ALF Ltd. selected Debonya Limited, for acquisition, as this was the company which could offer ALF Ltd., a growth potential to expand the market share, gain access to new R&D and automation processes, and above all achieve operational synergies in its core pharma manufacturing sector. Eventually ALF Ltd. aqcuired Debonya Limited in a business combination on 1st April, 2025.

Based on the above facts, answer the following questions :

(c)Heading the special team assigned with the task of proposing and finalising a merger/ acquisition, you very well understand that there are host of factors from the economic, commercial and legal perspective, which require consideration before initiating a merger or amalgamation exercise. Create a detailed list of such factors before initiating the assigned task.

December 2025Q. 1(d)5 marksSyllabus 2022
Show the facts common to all parts of Q. 1

Alkasa Lifesciences Limited (ALF Ltd.), a public limited company, is a healthcare conglomerate, with its operations in four major verticals–Pharmaceutical Manufacturing, Medical Equipment, Wellness and Nutrition Products and Diagnostics. ALF Ltd.’s, 75-year-old traditional Pharma business, is the backbone of the company. However, over the past few years, the company has expanded its operations through the Wellness and Nutrition division which has experienced rapid growth, driven by rising demand for preventive health products. Evercare Path Labs, a wholly owned subsidiary, is yet another diversification venture of ALF Ltd. which though is a high-growth unit but lacks synergy with the other pharma activities.

The stakeholders have raised concerns that the company’s diversified structure might dilute the overall performance and valuation of the company. Investing too much in expansion without a clear strategy can make the business vulnerable to market changes or operational failures, increasing the risk of substantial financial losses. Hence, they suggest to shed off the non-core units to focus on core areas. But the management feels a strong sense of ownership and pride over the units they have personally developed and nurtured, making it difficult to let them go. Hence the suggestion of divestiture is completely unacceptable to them.

In response to this deadlock, the Board of Directors have hired Mr. Agrim Basu as their Strategic advisor for exploring strategic options to unlock the value of the high-growth divisions and improving focus on its core pharmaceutical operations. Mr. Basu has suggested a scheme explaining that the company may opt for a divestiture, capital restructuring, buyback and acquisitions/mergers as part of a strategic initiative to enhance shareholder value and optimize operational focus. Together, these steps will reflect proactive financial management and strategic clarity, positioning the company for sustainable long-term growth while maintaining investor trust and market competitiveness.

Convinced with the suggestions of Mr. Basu, the following scheme is formulated :

•Divest Evercare Path Labs or Separate Evercare Path Labs for value unlocking (via carveout) as diagnostics business no longer aligns with ALF Ltd.’s long-term strategic direction.

•Use proceeds from above step to repay high-interest debt of ₹ 500 crore to improve debtequity ratio and further support financial stability.

•Further, a buyback of shares under Section 68 of the Companies Act, 2013, utilizing ₹ 800 crores of the proceeds. Improved EPS from buyback may help in market perception during future takeover bids, potentially reducing acquisition cost.

•With remaining proceeds and a stronger financial position post-buyback, ALF Ltd. will be all set for mergers/acquisition.

The process of merging with another company or acquiring a company is complex. In addition to the legal ramifications, companies must be aware of the potential tax implications as well as ensuring that the terms of the deal benefit both parties.

ALF Ltd. has created a team of strategic advisors, lawyers and professionals to negotiate on their behalf in order to obtain the best possible deal within the framework of the applicable laws.

After rounds of deliberations and due diligence of various options proposed by the special team, ALF Ltd. selected Debonya Limited, for acquisition, as this was the company which could offer ALF Ltd., a growth potential to expand the market share, gain access to new R&D and automation processes, and above all achieve operational synergies in its core pharma manufacturing sector. Eventually ALF Ltd. aqcuired Debonya Limited in a business combination on 1st April, 2025.

Based on the above facts, answer the following questions :

(d)At the time of preacquisition legal due diligence of Debonya Limited by the special team, it came to light that Debonya Limited is facing a lawsuit filed by a customer alleging allergical nature of its products with a potential liability of ₹ 30,00,000. Hence, as part of the acquisition agreement, the sellers of Debonya Limited provided an indemnification to Alkasa Lifesciences Limited for the reimbursement of any losses greater than ₹ 12,00,000. At the acquisition date, Alkasa Lifesciences Limited recognises the fair value of the contingent liability of ₹ 30,00,000 in the acquisition accounting. Calculate the amount of indemnification asset while doing the acquisition accounting in Alkasa Lifesciences Limited. Also brief the management about the concept and treatment of indemnification asset and discuss under what circumstances such assets are recognized.

June 2025Q. 3(b)3 marksSyllabus 2017

(b)Merger or Amalgamation is undertaken for acquiring cash resources, eliminating competition, saving on taxes or influencing the economies of large-scale operations.

List out some of the factors, which require consideration before initiating a merger or amalgamation exercise from the economic, commercial and legal perspective.

June 2025Q. 1(c)5 marksSyllabus 2022
Show the facts common to all parts of Q. 1

Pysunsmart Fire Protection Limited (PFPL) is a listed company on the Bombay Stock Exchange (BSE). It is engaged in the manufacture of industrial fire extinguishers. The company has seen a steady growth over the past few years and has attained a robust market presence. The company’s stock has been gaining attention due to company’s strong pipeline of upcoming new products and expansion into new markets. As a result, the stock price of (PFPL) has been steadily rising.

A and B have been close friends and business partners over years. Over time, they have started investing jointly in several listed company, including PFPL.

C is a majority shareholder of a company “C holdings” and has also expressed his interest to purchase more shares in PFPL through C holdings and has been in talks with A, B, and Z about a potential joint acquisition strategy to gain control over the company.

Z a prominent investor has been closely monitoring the performance of PFPL. He believes that PFPL is undervalued relative to its growth prospects. He has identified that if the company’s product pipeline succeeds, it could increase the company’s market capitalization significantly. He already holds 20% shares in PFPL and is interested in increasing his stake further.

While all these shareholders have not made any formal agreements with each other but they have had multiple informal meetings where they discussed the possibility of working together.

PFPL had conducted a buy back through an open offer in order to improve its earning per share (EPS) and boost stock prices. Due to this, the total number of shares of PFPL in circulation decreased and as a result the shareholding of one shareholder, Q, increased from 24% to 28%.

PFPL is also considering proposals for merger with Sangam Limited, a manufacturer in same product. PFPL has attained a robust market presence in North India but operating at a much smaller scale in south. Merger with Sangam Limited will open the avenues to increase its market share in South too. The board of directors of PFPL have shown keen interest in doing premerger due diligence as they want to ensure the post-merger success. Though they have not received any red flag from any other department but HR head who is a part of premerger due diligence team has raised a concern. PFPL has a formal corporate culture, with a hierarchical structure whereas the employees of Sangam Limited are young and thrive in a culture that values innovation and informality. Sangam Limited operates in a flat structure where decision making is quick and decentralized. The HR Department of PFPL wants to draw attention to the problems that might come up regarding the cultural integration and human aspects of combining these companies who are having starkly different cultures. A meeting of Board of Directors has been called to discuss the matter.

Based on the above facts, answer the following questions :

(c)The acquiring companies often use cash deals or stock deals for acquisition. Differentiate between the two, enumerating the advantages of cash deals and stock deals. What are the considerations to be kept in mind while making a choice between the two ?

June 2025Q. 1(d)5 marksSyllabus 2022
Show the facts common to all parts of Q. 1

Pysunsmart Fire Protection Limited (PFPL) is a listed company on the Bombay Stock Exchange (BSE). It is engaged in the manufacture of industrial fire extinguishers. The company has seen a steady growth over the past few years and has attained a robust market presence. The company’s stock has been gaining attention due to company’s strong pipeline of upcoming new products and expansion into new markets. As a result, the stock price of (PFPL) has been steadily rising.

A and B have been close friends and business partners over years. Over time, they have started investing jointly in several listed company, including PFPL.

C is a majority shareholder of a company “C holdings” and has also expressed his interest to purchase more shares in PFPL through C holdings and has been in talks with A, B, and Z about a potential joint acquisition strategy to gain control over the company.

Z a prominent investor has been closely monitoring the performance of PFPL. He believes that PFPL is undervalued relative to its growth prospects. He has identified that if the company’s product pipeline succeeds, it could increase the company’s market capitalization significantly. He already holds 20% shares in PFPL and is interested in increasing his stake further.

While all these shareholders have not made any formal agreements with each other but they have had multiple informal meetings where they discussed the possibility of working together.

PFPL had conducted a buy back through an open offer in order to improve its earning per share (EPS) and boost stock prices. Due to this, the total number of shares of PFPL in circulation decreased and as a result the shareholding of one shareholder, Q, increased from 24% to 28%.

PFPL is also considering proposals for merger with Sangam Limited, a manufacturer in same product. PFPL has attained a robust market presence in North India but operating at a much smaller scale in south. Merger with Sangam Limited will open the avenues to increase its market share in South too. The board of directors of PFPL have shown keen interest in doing premerger due diligence as they want to ensure the post-merger success. Though they have not received any red flag from any other department but HR head who is a part of premerger due diligence team has raised a concern. PFPL has a formal corporate culture, with a hierarchical structure whereas the employees of Sangam Limited are young and thrive in a culture that values innovation and informality. Sangam Limited operates in a flat structure where decision making is quick and decentralized. The HR Department of PFPL wants to draw attention to the problems that might come up regarding the cultural integration and human aspects of combining these companies who are having starkly different cultures. A meeting of Board of Directors has been called to discuss the matter.

Based on the above facts, answer the following questions :

(d)The HR Head strongly believes one modification that has great potential to affect the merged entity is a change in the organizational structure. Regardless of whether the change is large or small, planning and an intense analysis are vital to creating a decision-making and communication framework that will support post-merger objectives and help the new business grow. As the member of the HR team, what do you suggest to synchronise these differences in culture and organizational structure of Sangam Limited and PFPL especially during the premerger diligence.

December 2024Q. 2A(ii)5 marksSyllabus 2017

(ii)“Due diligence is an investigation or audit of a potential investment. It seeks to confirm all material facts in regard to a sale. It is a way of preventing unnecessary harm/ hassles to either party involved in a transaction.” Explain the statement.

December 2024Q. 1(a)5 marksSyllabus 2022
Show the facts common to all parts of Q. 1

ETA Motors Ltd. is an Indian automotive company, headquartered and registered in Delhi, incorporated on 12th May, 2002. The company manufactures vans and buses. The technical experts of the company have an opinion that four critical technological disruptions – mobility, autonomous driving, electric vehicles, and connected technologies – are poised to revolutionize the automotive landscape. The Company besides its plan to increase its market share by 20% to 35% by 2025-26, wants to enter the global market through joint ventures or technology transfers. The company decided to chalk out an expansion strategy for the same.

K&G Associates, the official and legal advisors to the Company were asked to deliberate on the expansion strategies. In their presentation to the Board of directors of ETA Motors Ltd., they explained that Mergers and Acquisitions (M&A) and Takeovers are common occurrences in the business world as entities aim for inorganic growth and diversification. By merging, the companies hope to reap the benefits by becoming bigger and dominating and also through tax benefits, economies of scale, acquiring new technology and improved market reach and industry visibility. After gaining an insight into the M&A opportunities, ETA Motors Ltd. created a separate (M&A) team to look out for acquisition targets as the Board of Directors felt that strategic assessments of companies, industry expertise, due diligence, merger integration, and operational improvements represent areas where knowledge and skills are required for the success of a merger or acquisition.

(M&A) team was assigned the task to do the investigating effort and to gather all relevant facts and information about the targets that can influence a decision to enter into a transaction or not. M&A team after their detailed due diligence recommended an unlisted company, Daisy

Commercial Vehicle Company Ltd. (DCVL) in South India as a potential target to give ETA Motors Ltd. a major breakthrough on the expansion front. The acquisition offer seemed to open up possibilities for strong synergies like expansion of the product line, good R&D capabilities and new markets.

As Merger & Acquisition process is normally proceeded by formulation of strategy, carrying out due diligence, conducting valuation, ensuring all legal compliances and considering the aspects of stamp duty and other applications, K&G Associates was consulted regarding legal procedures and compliances under various acts and also regarding the valuation aspects of shares.

Both the companies deliberated and discussed together at the Board level and came out with a scheme. The scheme received approval of 96% of the shareholders of DCVL but rest 4% dissented from the scheme.

K&G Associates advised that Section 235 and 236 of the Companies Act, 2013 lays down legal requirements for purpose of takeover of an unlisted company through transfer of undertaking to another company. Where the scheme has been approved by the holders of not less than nine tenth (90%) in value of the shares of the DCVL whose transfer is involved, ETA Motors Ltd., may give notice to the dissenting shareholders that transferee company desires to acquire their shares. The scheme shall be binding on all the shareholders of the DCVL (including dissenting shareholders), unless the Tribunal orders otherwise (i.e., that the scheme shall not be binding on all shareholders). Accordingly, the ETA Motors Ltd. shall be entitled and bound to acquire these shares on the terms on which it acquires under the scheme (the binding provision).

Accordingly, the circular along with all information as provided in the Act was sent to the dissenting shareholders in Form No : CAA 14 to the last known address of the dissenting shareholders. Some of the shareholders held their shares in DEMAT form.

Based on the above facts, answer the following questions :

(a)Due diligence is a meaningful analysis of the collected information to arrive at some decision about the potential transaction. Explain the various types of Due diligence which could be conducted by M&A team while finalising a potential company for takeover.

December 2023Q. 1(b)5 marksSyllabus 2017

(b)Due Diligence is an important exercise for any potential investment proposal. Discuss the importance of due diligence for a proposed Merger. Also enumerate the types of due diligence which may be taken for such a proposal.

December 2021Q. 2(c)5 marksSyllabus 2017

(c)In order to assess the nitty-gritty of the transactions of the takeover and to opt for or opt out of the takeover deal, due diligence is carried out. As a practicing company secretary, what various aspects would you consider while carrying out due diligence with regard to Management?

December 2020Q. 1(a)5 marksOld syllabus

(a)‘‘Approval of a scheme of amalgamation between two banking companies requires Board of Directors of the involved banking Companies to pay attention particularly on certain matters.’’

Explain briefly the guidelines mandated by Reserve Bank of India in this regard.

December 2018Q. 2A(i)5 marksOld syllabus

(i)“Due Diligence starts much before the process of restructuring and helps in better negotiation of deals, to handle taxation and stamp duty aspects in better manner, to minimise and resolve the human and cultural issues that may arise out of mergers/ amalgamation etc”. Discuss the statement in view of the fact that Due Diligence is considered as ‘background check’.

June 2026Q. 1(d)5 marksSyllabus 2022
Show the facts common to all parts of Q. 1

The Indian healthcare sector is undergoing rapid consolidation. ‘‘Aarogya Healthcare,’’ a large, publicly listed hospital chain with a strong presence in South India, is looking to expand its reach and service offerings. They have identified ‘‘Swasth Jeevan Clinics,’’ a smaller but well -regarded chain of clinics specializing in primary care and diagnostics, as an attractive acquisition target. Swasth Jeevan Clinics has a strong brand reputation in Western India and a loyal patient base.

Aarogya Healthcare believes that acquiring Swasth Jeevan Clinics will:

•Expand its geographic footprint into Western India.

•Diversify its service offerings into primary care and diagnostics.

•Gain access to Swasth Jeevan Clinics’ established patient base a nd brand.

•Achieve synergies through economies of scale and shared resources.

The proposed transaction is structured as an amalgamation, where Swasth Jeevan Clinics will merge into Aarogya Healthcare.

Key Individuals:

•Dr. Lakshmi Reddy : CEO of Aarogya Healthcare

•Mr. Sanjay Desai : CFO of Aarogya Healthcare

•Dr. Priya Sharma : CEO of Swasth Jeevan Clinics

•Mr. Rohan Verma : Lead Partner at ‘‘Verma and Associates,’’ the investment bank advising Aarogya Healthcare.

(d)Dr. Priya Sharma, the CEO of Swasth Jeevan Clinics, is concerned about the integration process and ensuring a smooth transition for her employees and patients.

•Identify two potential cultural differences that could exist between Aarogya Healthcare and Swasth Jeevan Clinics.

•For each cultural difference, suggest a specific strategy that Dr. Lakshmi Reddy, the CEO of Aarogya Healthcare, could use to promote a successful integration and minimize disruption.

December 2024Q. 4(c)5 marksSyllabus 2017

(c)Contracts entered into and in force need to be replaced by fresh contracts after merger or takeovers of entities, pursuant to orders passed by Courts or Tribunals.” Do you agree ? Give reasons.

December 2019Q. 2(c)5 marksOld syllabus

(c)“Contracts entered into and in force need to be replaced by fresh contracts after merged or takeovers entities that have been integrated pursuant orders passed by Courts or Tribunals.” Do you agree ?

June 2019Q. 2A(iii)5 marksOld syllabus

(iii)The main purpose of a merger or acquisition is to achieve the expected financial results namely the earnings and cash flow. But there are certain other measures that serve as key indicators for measuring post merger efficiency. What are these key indicators ?

December 2018Q. 3(b)3 marksOld syllabus

(b)Corporates encounter pitfalls in post-merger statutory approval due to certain common errors, that need to be taken care of. Try to point out certain errors that need to be taken care of.

June 2024Q. 2A(iii)5 marksSyllabus 2017

(iii)A Ltd. was a listed company with Kanpur Stock Exchange but delisted in 2012. In the year 2017, the Board passed a resolution approving a scheme of arrangement and petitioned before the National Company Law Tribunal (NCLT). Subsequent to that, scheme was placed before the members. Two (2) shareholders holding 80% shares opposed the scheme. As a Company Secretary, what would you advice to the Board next course of action(s) pursuant to the provisions of the Companies Act, 2013.

December 2023Q. 1(a)5 marksSyllabus 2017

(a)ABC Ltd. is planning for merger with RST Ltd. As a Company Secretary you have advised your management that all shareholders of transferor and transferee can give consent for the merger and thereby the shareholders meeting can be dispensed to save the time. However, CFO of your Company has raised a doubt on your view. Hence, the matter was put before a practicing Company Secretary, who will advise on the matter to the Company. As a practicing Company Secretary referring relevant provision and a case law give your opinion on the matter.

June 2021Q. 3(e)3 marksSyllabus 2017

(e)HIJ Entertainment LLP desires to amalgamate as transferor with LMN Exhibitors Ltd. Is it permissible ?

December 2020Q. 2A(ii)5 marksSyllabus 2017

(ii)A meeting of members of Jwala International Ltd. was held as per the Orders of the Tribunal for considering a scheme of compromise and arrangement in which 300 members holding 10,00,000 shares were present. 130 members holding 6,00,000 shares voted in favor, 120 members holding 1,00,000 shares voted against and remaining 50 members with 3,00,000 shares abstained. Examine with reference to provisions of the Companies Act, 2013 as to whether the scheme is approved ?

December 2019Q. 1(c)5 marksOld syllabus

(c)“Dissatisfactory implementation of sanctioned compromise and arrangement for amalgamation or merger may lead to liquidation.” Examine the statement in relation to powers of Tribunal in terms of Companies Act, 2013.

December 2019Q. 1(d)5 marksOld syllabus

(d)“Non-compliance or contravention of the requirements prescribed under the Companies Act, 2013 and rules framed thereunder in framing or implementing the scheme of a compromise, arrangement involving transferor and transferee Companies may lead to prosecution.” Briefly explain.

June 2019Q. 1(d)5 marksOld syllabus

(d)“Amalgamation of Government Companies requires a simplified procedure for compliance’’.

List out the steps involved upto the stage of approval by Central Government for amalgamation of Government companies.

No questions in this chapter match these filters.

Also relevant to this chapter

  • December 2024, Q. 1(c) · As the legal advisor of the company, guide the company regarding determination of the price to be paid by acquirer for purchase of equity sh… (Ch. 3)
  • December 2024, Q. 1(d) · Will the takeover achieved in the above process fall within the meaning of amalgamation under the Income Tax Act, 1961 and will benefits of … (Ch. 7)